Oncology Billing Services

Full-service revenue cycle and patient contact center solutions focused on maximizing operating margin.

Screenshot-2025-11-21-090158

Designed to match your organization’s unique revenue cycle management needs.

Oncology Revenue Cycle Management Services

Custom-tailored oncology revenue cycle management services to match your organization’s unique needs.

Oncology billing is a nuanced, multistep process with little room for error. Unfortunately, even one billing-related mistake can present major financial obstacles for timely reimbursement and patient care.

Global Healthcare Resource understands the unique complexities of oncology billing and has over 25 years of experience delivering cost-effective revenue cycle services to healthcare organizations across the United States. Ongoing inefficiencies within your billing cycle can create challenges beyond administrative burdens — revenue cycle problems can ultimately affect the treatment patients receive and their overall satisfaction with your organization. 

To deliver the best service possible, it is essential to have an experienced billing partner working alongside your oncology professionals.

Schedule a Meeting

End-to-End Revenue Cycle Management for Oncology

When you outsource your revenue cycle processes to Global Healthcare Resource, you will benefit from medical coding, billing, and call center teams of tenured professionals with vast knowledge of oncology-specific nuances. We can integrate with any EHR platform you use and analyze your existing processes to create a customized plan that streamlines and improves your productivity.

Our teams provide flexible coverage for each stage of your revenue cycle:

01-8-Benefits-of-Medical-Coding-Outsourcing-1

Coding for Oncology Claims

Oncology billing sits at the intersection of clinical complexity and financial risk. Capturing the full cost of care requires specialized knowledge across treatment protocols, pharmacology, and code-sequencing rules. Infusion therapy demands precise sequencing of primary, secondary, and concurrent services, while billing for high-cost chemotherapy agents through J-codes requires exact drug identification, dosage reconciliation, and airtight documentation. Underpayments in oncology can cause significant revenue losses and affect the financial viability of delivering these treatments.

Our certified oncology coders maintain their expertise through continuous, specialty-focused training across CPT, ICD-10-CM, and HCPCS code sets. They know how to apply NCCN guidelines within the context of complex, multidrug regimens and navigate payer-specific requirements for specialty drugs. Every claim reflects a deliberate alignment between clinical documentation and the codes submitted, protecting your revenue and reducing your audit exposure.

Why Partner With Global Healthcare Resource?

Our benefits are well documented. From the moment you partner with us, you can expect the following benefits:

Transform Your Oncology Revenue Cycle Management Today

With decades of experience in industries like yours, our skilled billing professionals are ready to get started. Connect with us today and schedule a meeting so you can see what we do firsthand. We look forward to becoming an extension of your team!

Screenshot-2025-11-18-125419

Latest News

Frequently Asked Questions

Oncology billing involves high-cost specialty drugs, complex administration and infusion coding, prolonged treatment courses, and intensive prior authorization requirements, all of which are under heavy payer scrutiny. The financial stakes of a single coding error are significantly higher than in most other fields.

J-codes are part of the HCPCS code set used to identify specific injectable drugs, including chemotherapy and immunotherapy agents. Billing the correct J-code and units is critical for receiving accurate — and often substantial — reimbursement for these expensive drugs.

Nearly all chemotherapy and radiation treatments require prior authorization. A failure to secure it before treatment begins leads to an almost certain high-value denial, which can delay critical patient care, cause significant revenue loss, and create a poor patient financial experience.